The relevance of the optional use of fasting in laboratory measurements that make up the lipid profile: A systematic literature review

被引:0
|
作者
de Oliveira, Aliene Dias [1 ]
dos Santos, Amanda Ribeiro [1 ]
de Oliveira, Livia Costa [2 ]
Neto, Jose Firmino Nogueira [1 ]
机构
[1] State Univ Rio de Janeiro UERJ, Piquet Carneiro Polyclin, Lipid Lab, 381 Marechal Rondon Ave, BR-20950003 Rio De Janeiro, RJ, Brazil
[2] Natl Canc Inst Jose Alencar Gomes da Silva INCA, Palliat Care Unit, 274 Visconde Santa Isabel St, BR-20560121 Rio De Janeiro, RJ, Brazil
关键词
Fasting; Dyslipidemia; Lipid profile; Lipoproteins; Non-HDL-c; DENSITY-LIPOPROTEIN CHOLESTEROL; NONFASTING TRIGLYCERIDES; CARDIOVASCULAR EVENTS; RISK; MANAGEMENT; APOLIPOPROTEINS; DYSLIPIDEMIA; ASSOCIATION; METABOLISM; PLASMA;
D O I
10.1016/j.jpba.2023.115925
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
The objective of this study was to evaluate the impact of fasting easing on laboratory measurements of the lipid profile, in order to contribute to the fidelity of interpretation of laboratory results. Starting in October 2022, a Systematic Literature Review (SRL) was carried out, using articles indexed in the electronic databases PubMed/ MEDLINE, EMBASE, Scopus, LILACS and Cochrane Library, following the guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-Analyzes Group (PRISMA). This RSL was registered with PROSPERO, under registration number CRD42022370007. For inclusion, articles had to be original and developed in humans. After evaluating the methodological quality and analyzing the risk of bias, we obtained 16 articles published between 1994 and 2021, providing data on a total of 398,709 individuals, aged between 3 and 93 years. According to the selected studies, lipid profile measurements performed with flexible fasting, in addition to bringing benefits to patients and the pre-analytical system of the clinical laboratory, are more suitable for determining cardiovascular risk, mainly through the assessment of values obtained in the determination of triglycerides. It is therefore concluded that the optional use of fasting must be established through medical advice. In addition, laboratory methods and readings must be readjusted to this reality, informing through the report the parameters related to the lipid profile with and without the use of a 12-hour fast.
引用
收藏
页数:11
相关论文
共 5 条
  • [1] Impact of Ramadan fasting on lipid profile, uric acid, and HbA1c in CKD: A systematic review and meta-analysis
    Ashkbari, Ali
    Nikbakht, Hossein-Ali
    Amirkhanlou, Saeid
    Elahi, Ghazaleh
    Salahi, Marjan
    Ebrahimi, Sareh
    Golfiroozi, Saeed
    Hosseini, Seyed Ahmad
    Ghelichi-Ghojogh, Mousa
    PRIMARY CARE DIABETES, 2024, 18 (03) : 277 - 283
  • [2] Effects of intermittent fasting and energy-restricted diets on lipid profile: A systematic review and meta-analysis
    Meng, Haiyan
    Zhu, Lei
    Kord-Varkaneh, Hamed
    Santos, Heitor O.
    Tinsley, Grant M.
    Fu, Peng
    NUTRITION, 2020, 77
  • [3] Effect of carnosine supplementation on lipid profile, fasting blood glucose, HbA1C and insulin resistance: A systematic review and meta-analysis of long-term randomized controlled trials
    Peng, Weixia
    Mao, Peijun
    Liu, Lijun
    Chen, Keli
    Zhong, Yaqin
    Xia, Wenping
    Guo, Qiaohong
    Tan, Shing Cheng
    Rahmani, Jamal
    Varkaneh, Hamed Kord
    He, Peixiang
    COMPLEMENTARY THERAPIES IN MEDICINE, 2020, 48
  • [4] Effect of caper fruit (Capparis spinosa L.) consumption on liver enzymes, lipid profile, fasting plasma glucose, and weight loss. A systematic review and a preliminary meta-analysis of randomized controlled trials
    Perna, Simone
    Rafique, Ayesha
    Rondanelli, Mariangela
    Allehdan, Sabika
    Riso, Patrizia
    Marino, Mirko
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 168
  • [5] Curcumin effects on glycaemic indices, lipid profile, blood pressure, inflammatory markers and anthropometric measurements of non-alcoholic fatty liver disease patients: A systematic review and meta-analysis of randomized clinical trials
    Ebrahimzadeh, Armin
    Mohseni, Shokouh
    Safargar, Mohammad
    Mohtashamian, Abbas
    Niknam, Sara
    Bakhoda, Mohammadreza
    Afshari, Sanaz
    Jafari, Amirhossein
    Ebrahimzadeh, Anahita
    Fooladshekan, Sara
    Mohtashami, Alireza
    Ferns, Gordon A.
    Babajafari, Siavash
    Sohrabi, Zahra
    COMPLEMENTARY THERAPIES IN MEDICINE, 2024, 80